Ghent University Academic Bibliography

Show Sort by

Your filters: cql: parent exact "ANNALS OF ONCOLOGY"

Add to list
- Journal Article
- A1
- open access
European experts consensus : BRCA/homologous recombination deficiency testing in first-line ovarian cancer

I. Vergote, A. González-Martín, I. Ray-Coquard, P. Harter, N. Colombo, P. Pujol, D. Lorusso, M.R. Mirza, B. Brasiuniene, R. Madry, et al.

(2022) ANNALS OF ONCOLOGY. 33(3). p.276-287
Add to list
- Conference Paper
- C3
Pembrolizumab, SBRT, and immunomodulation for recurrent and/or refractory cervical or endometrial carcinoma

Emiel De Jaeghere (UGent) , Sandra Tuyaerts, Ann M.T. Van Nuffel, Lien Lippens (UGent) , An Hendrix (UGent) , P. Vuylsteke, S. Henry, X.B. Trinh, P.A. Van Dam, S. Aspeslagh, et al.

(2021) ANNALS OF ONCOLOGY. In Annals of Oncology 32(Supplement 7). p.S1449-S1450
Add to list
- Miscellaneous
Gene expression signatures for tailoring adjuvant chemotherapy of luminal breast cancer : the pathologists' perspective

R. Salgado, V. Peg, J. Ruschoff, A. Vincent-Salomon, I. Castellano, S. Perner, Koen Van de Vijver (UGent) , C. M. Quinn and Z. Varga

(2021) ANNALS OF ONCOLOGY. 32(11). p.1316-1321
Add to list
The potential influence of human Y-chromosome haplogroup on COVID-19 prevalence and mortality

Joris Delanghe (UGent) , Marc De Buyzere (UGent) , Sander De Bruyne (UGent) , Wim Van Criekinge (UGent) and Marijn Speeckaert (UGent)

(2020) ANNALS OF ONCOLOGY. 31(11). p.1582-1584
Add to list
Prostate cancer : ESMO clinical practice guidelines for diagnosis, treatment and follow-up

C. Parker, E. Castro, K. Fizazi, A. Heidenreich, Piet Ost (UGent) , G. Procopio, B. Tombal and S. Gillessen

(2020) ANNALS OF ONCOLOGY. 31(9). p.1119-1134
Add to list
Man against machine reloaded : performance of a market-approved convolutional neural network in classifying a broad spectrum of skin lesions in comparison with 96 dermatologists working under less artificial conditions

H.A. Haenssle, C. Fink, F. Toberer, J. Winkler, W. Stolz, T. Deinlein, R. Hofmann-Wellenhof, A. Lallas, S. Emmert, T. Buhl, et al.

(2020) ANNALS OF ONCOLOGY. 31(1). p.137-143
Add to list
A phase I/II trial of radium-223 (Ra-223) in combination with pembrolizumab in patients (pts) with stage IV non-small cell lung cancer (NSCLC)

M. Reck, K. F. Mileham, D. A. Clump, L. Decoster, A. Estival, E. Felip, P. Fried, L. Paz-Ares, M. Sebastian, N Vinolas Segarra, et al.

(2020) ANNALS OF ONCOLOGY. 31(Suppl 4). p.S897-S898
Add to list
- Conference Paper
- C3
Splenic metabolic activity as biomarker in cervical cancer

Emiel De Jaeghere (UGent) , Frederiek Laloo (UGent) , Lien Lippens (UGent) , Kathia De Man (UGent) , Mieke Van Bockstal, Koen Van de Vijver (UGent) , Philippe Tummers (UGent) , Amin Makar (UGent) , Pieter De Visschere (UGent) , Olivier De Wever (UGent) , et al.

(2019) ANNALS OF ONCOLOGY. 30(5).
Add to list
- Conference Paper
- C3
miRNA expression profiles in BRCA1-associated breast cancers reveal upregulation of specific miRNAs in tumors lacking a clear second hit in a large proportion of the tumour

Mattias Van Heetvelde (UGent) , Mieke R Van Bockstal, Jo Van Dorpe (UGent) , Kim De Leeneer (UGent) , Anne Vral (UGent) and Kathleen Claes (UGent)

(2019) ANNALS OF ONCOLOGY. 30(suppl. 3).
Add to list
EAU-ESMO consensus statements on the management of advanced and variant bladder cancer - an international collaborative multi-stakeholder effort : under the auspices of the EAU and ESMO Guidelines Committees

A Horwich, M Babjuk, J Bellmunt, HM Bruins, TM De Reijke, M De Santis, S Gillessen, N James, S Maclennan, J Palou, et al.

(2019) ANNALS OF ONCOLOGY. 30(11). p.1697-1727

Academic Bibliography

European experts consensus : BRCA/homologous recombination deficiency testing in first-line ovarian cancer

Pembrolizumab, SBRT, and immunomodulation for recurrent and/or refractory cervical or endometrial carcinoma

Gene expression signatures for tailoring adjuvant chemotherapy of luminal breast cancer : the pathologists' perspective

The potential influence of human Y-chromosome haplogroup on COVID-19 prevalence and mortality

Prostate cancer : ESMO clinical practice guidelines for diagnosis, treatment and follow-up

Man against machine reloaded : performance of a market-approved convolutional neural network in classifying a broad spectrum of skin lesions in comparison with 96 dermatologists working under less artificial conditions

A phase I/II trial of radium-223 (Ra-223) in combination with pembrolizumab in patients (pts) with stage IV non-small cell lung cancer (NSCLC)

Splenic metabolic activity as biomarker in cervical cancer

miRNA expression profiles in BRCA1-associated breast cancers reveal upregulation of specific miRNAs in tumors lacking a clear second hit in a large proportion of the tumour

EAU-ESMO consensus statements on the management of advanced and variant bladder cancer - an international collaborative multi-stakeholder effort : under the auspices of the EAU and ESMO Guidelines Committees

Contents

Support

Contact